NL-OMON34123撤回2 期
A phase I/ II study ;Efficacy and safety of alpha/ beta T- /CD19B-cell depleted allogeneic haematopoietic stem cells transplantation in high risk or relapsed acute leukaemia / MDS followed by an innate donor lymphocyte infusion (iDLI) - Allo-SCT and innate donor lymphocyte infusion
niversitair Medisch Centrum Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age 18-65 years
- •Meeting the criteria for a allo-SCT and high risk leukemic disease
- •WHO performance status * 2
- •Written informed consent
排除标准
- •Relapse of allo-SCT within 6 months after allo-SCT
- •Relapse acute promyelocyten leukemia
- •Bilirubin and/or transaminases > 2.5 x normal value
- •Creatinine clearance < 40 ml/min
- •Cardiac dysfunction
- •Active, uncontrolled infection
- •HIV positivity
研究者
相似试验
已完成
2 期
A phase I/ II study;Efficacy and safety of alpha / beta T- /CD19B-cell depleted allogeneic haematopoietic stem cells transplantation in high risk or relapsed acute leukaemia / MDS followed by an innate donor lymphocyte infusion (iDLI)leukemia bloodcancer10024324NL-OMON35919niversitair Medisch Centrum Utrecht30
进行中（未招募）
不适用
A phase I/ II studyEfficacy and safety of alpha/beta T- /CD19B-cell depleted allogeneic haematopoietic stem cells transplantation in high risk or relapsed acute leukaemia / MDS followed by an innate donor lymphocyte infusion (iDLI) - iDLIEUCTR2010-021221-12-NLMC30
已完成
2 期
Phase II study of safety and efficacy of alternating R-CHOP and R-HDMA therapy in high-risk diffuse large B-cell lymphomadiffuse large B-cell lymphomaJPRN-UMIN000031459Division of Hematology, Keio University School of Medicine5
招募中
不适用
Investigation for efficacy and safety of [18F] C05-05Dementia with Lewy bodies, Parkinson's disease, and multiple system atrophyD020961, D010300, D019578JPRN-jRCTs031220123Endo Hironobu91
招募中
不适用
Investigation for efficacy and safety of [18F] SPAL-T-06Dementia with Lewy bodies, Parkinson's disease, and multiple system atrophyD020961, D010300, D019578JPRN-jRCTs031210180Endo Hironobu30